Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 5 (2008), Issue 7 (July)

1. Unusual case of adenocarcinoma arising in endometriosis mimicking colorectal cancer in a young woman with a Müllerian anomaly.
   Fertil Steril, 90(1): 199.e13-5. [Abstract] [Full-text]
2. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.
   Clin Cancer Res, 14(13): 4259-66. [Abstract] [Full-text]
3. Moscatilin induces apoptosis in human colorectal cancer cells: a crucial role of c-Jun NH2-terminal protein kinase activation caused by tubulin depolymerization and DNA damage.
   Clin Cancer Res, 14(13): 4250-8. [Abstract] [Full-text]
4. Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome.
   Clin Cancer Res, 14(13): 4219-24. [Abstract] [Full-text]
5. Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).
   Clin Cancer Res, 14(13): 4192-9. [Abstract] [Full-text]
6. Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers.
   Clin Cancer Res, 14(13): 4128-33. [Abstract] [Full-text]
7. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
   J Natl Cancer Inst, 100(13): 950-61. [Abstract] [Full-text]
8. Multiple loci with different cancer specificities within the 8q24 gene desert.
   J Natl Cancer Inst, 100(13): 962-6. [Abstract] [Full-text]
9. Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients.
   Br J Cancer, 99(1): 83-9. [Abstract] [Full-text]
10. Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study.
    Br J Cancer, 99(1): 133-5. [Abstract] [Full-text]
11. Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa.
    Br J Cancer, 99(1): 136-42. [Abstract] [Full-text]
12. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Dig Dis Sci, 53(8): 2195-203. [Abstract] [Full-text]
13. Serrated adenoma is a risk factor for subsequent adenomatous polyps.
    Dig Dis Sci, 53(8): 2204-7. [Abstract] [Full-text]
14. Immunohistochemical examination of anti-STn monoclonal antibodies LLU9B4, B72.3, and B35.2 for their potential use as tumor markers.
    Dig Dis Sci, 53(8): 2189-94. [Abstract] [Full-text]
15. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
    Dig Dis Sci, 53(8): 2183-8. [Abstract] [Full-text]
16. Protective effects of diets supplemented with omega-3 polyunsaturated fatty acids and calcium against colorectal tumor formation.
    Dig Dis Sci, 53(8): 2177-82. [Abstract] [Full-text]
17. Fibroblastic polyp of the colon and colonic perineurioma: 2 names for a single entity?
    Am J Surg Pathol, 32(7): 1088-94. [Abstract] [Full-text]
18. Multimedia article. Laparoscopic restorative proctocolectomy with small McBurney incision for ileal pouch construction without protective ileostomy.
    Dis Colon Rectum, 51(7): 1137-8. [Abstract] [Full-text]
19. Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review.
    Dis Colon Rectum, 51(7): 1139-45. [Abstract] [Full-text]
20. Hybrid Capture II detection of oncogenic human papillomavirus: a useful tool when evaluating men who have sex with men with atypical squamous cells of undetermined significance on anal cytology.
    Dis Colon Rectum, 51(7): 1130-6. [Abstract] [Full-text]
21. An innovative technique for colorectal specimen retrieval: a new era of "natural orifice specimen extraction" (N.O.S.E).
    Dis Colon Rectum, 51(7): 1120-4. [Abstract] [Full-text]
22. Transanal endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal masses.
    Dis Colon Rectum, 51(7): 1026-30; discussion 1030-1. [Abstract] [Full-text]
23. Impact of biopsy on the accuracy of endorectal ultrasound staging of rectal tumors.
    Dis Colon Rectum, 51(7): 1125-9. [Abstract] [Full-text]
24. Management of acquired rectourinary fistulas: how often and when is permanent fecal or urinary diversion necessary?
    Dis Colon Rectum, 51(7): 1049-54. [Abstract] [Full-text]
25. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
    Dis Colon Rectum, 51(7): 997-1003. [Abstract] [Full-text]
26. A prospective evaluation of sexual function and quality of life after ileal pouch-anal anastomosis.
    Dis Colon Rectum, 51(7): 1032-5. [Abstract] [Full-text]
27. Preoperative radiation response evaluated by 18-fluorodeoxyglucose positron emission tomography predicts survival in locally advanced rectal cancer.
    Dis Colon Rectum, 51(7): 1055-60. [Abstract] [Full-text]
28. Adenocarcinoma arising from the rectal stump eleven years after excision of an ileal J-pouch in a patient with ulcerative colitis: report of a case.
    Dis Colon Rectum, 51(7): 1146-8. [Abstract] [Full-text]
29. Fistula-associated anal adenocarcinoma: good results with aggressive therapy.
    Dis Colon Rectum, 51(7): 1061-7. [Abstract] [Full-text]
30. Implementation of quality measures to reduce surgical site infection in colorectal patients.
    Dis Colon Rectum, 51(7): 1004-9. [Abstract] [Full-text]
31. Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts.
    Cancer Lett, 267(1): 26-36. [Abstract] [Full-text]
32. Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon.
    J Histochem Cytochem, 56(8): 753-64. [Abstract] [Full-text]
33. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.
    J Clin Oncol, 26(20): 3434-9. [Abstract] [Full-text]
34. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
    J Clin Oncol, 26(20): 3411-7. [Abstract] [Full-text]
35. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
    Oncogene, 27(30): 4161-71. [Abstract] [Full-text]
36. Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.
    Clin Sci (Lond), 115(4): 107-27. [Abstract] [Full-text]
37. Hepatic ischemia-reperfusion increases vascular endothelial growth factor and cancer growth in rats.
    J Surg Res, 148(2): 158-63. [Abstract] [Full-text]
38. Preoperative chemoradiation followed by transanal excision for rectal cancer.
    J Surg Res, 148(2): 244-50. [Abstract] [Full-text]
39. Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors.
    BMC Cancer, 8: 185. [Abstract] [Full-text]
40. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
    BMC Cancer, 8: 178. [Abstract] [Full-text]
41. Phenotype and function of dendritic cells and T-lymphocyte polarization in the human colonic mucosa and adenocarcinoma.
    Eur J Surg Oncol, 34(8): 883-9. [Abstract] [Full-text]
42. Pulmonary resection of colorectal metastases in patients with or without a history of hepatic metastases.
    Eur J Surg Oncol, 34(8): 895-9. [Abstract] [Full-text]
43. Lymphatic mapping and sentinel lymph node biopsy in epidermoid carcinoma of the anal canal.
    Eur J Surg Oncol, 34(8): 890-4. [Abstract] [Full-text]
44. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.
    J Acquir Immune Defic Syndr, 48(4): 491-9. [Abstract] [Full-text]
45. A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation.
    J Pathol, 215(4): 445-56. [Abstract] [Full-text]
46. Genetic and epigenetic changes in colon cancer.
    Exp Mol Pathol, 85(1): 64-7. [Abstract] [Full-text]
47. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.
    J Invest Dermatol, 128(8): 2078-83. [Abstract] [Full-text]
48. UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study.
    Br J Cancer, 99(2): 275-82. [Abstract] [Full-text]
49. Inequity in colorectal cancer treatment and outcomes: a population-based study.
    Br J Cancer, 99(2): 266-74. [Abstract] [Full-text]
50. Asia Pacific consensus recommendations for colorectal cancer screening.
    Gut, 57(8): 1166-76. [Abstract] [Full-text]
51. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001.
    J Natl Cancer Inst, 100(14): 1003-12. [Abstract] [Full-text]
52. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions.
    Gut, 57(8): 1083-9. [Abstract] [Full-text]
53. Common variants in mismatch repair genes and risk of colorectal cancer.
    Gut, 57(8): 1097-101. [Abstract] [Full-text]
54. Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach.
    Gut, 57(8): 1090-6. [Abstract] [Full-text]
55. High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer.
    Am J Clin Pathol, 130(2): 247-53. [Abstract] [Full-text]
56. Presence of a TA haplotype in the APC gene containing the common 1822 polymorphism and colorectal adenoma.
    Cancer Res, 68(14): 6006-13. [Abstract] [Full-text]
57. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.
    Cancer Res, 68(14): 5795-802. [Abstract] [Full-text]
58. Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells.
    Cancer Res, 68(14): 5753-9. [Abstract] [Full-text]
59. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells.
    Cancer Res, 68(14): 5609-18. [Abstract] [Full-text]
60. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase.
    Mol Cell Biol, 28(15): 4665-74. [Abstract] [Full-text]
61. Should the surgeon or the general practitioner (GP) follow up patients after surgery for colon cancer? A randomized controlled trial protocol focusing on quality of life, cost-effectiveness and serious clinical events.
    BMC Health Serv Res, 8: 137. [Abstract] [Full-text]
62. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures.
    J Clin Oncol, 26(21): 3631-7. [Abstract] [Full-text]
63. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
    J Clin Oncol, 26(21): 3523-9. [Abstract] [Full-text]
64. Intermittent Pringle manoeuvre is not associated with adverse long-term prognosis after resection for colorectal liver metastases.
    Br J Surg, 95(8): 985-9. [Abstract] [Full-text]
65. Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer.
    Br J Surg, 95(8): 1012-9. [Abstract] [Full-text]
66. Urinary dysfunction after rectal cancer treatment is mainly caused by surgery.
    Br J Surg, 95(8): 1020-8. [Abstract] [Full-text]
67. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Br J Surg, 95(8): 1029-36. [Abstract] [Full-text]
68. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer.
    J Clin Oncol, 26(21): 3517-22. [Abstract] [Full-text]
69. Consumption of trans-fatty acid and its association with colorectal adenomas.
    Am J Epidemiol, 168(3): 289-97. [Abstract] [Full-text]
70. Diagnostic accuracy of 3.0-Tesla rectal magnetic resonance imaging in preoperative local staging of primary rectal cancer.
    Invest Radiol, 43(8): 587-93. [Abstract] [Full-text]
71. Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.
    Mol Pharmacol, 74(2): 476-84. [Abstract] [Full-text]
72. IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer.
    Int J Cancer, 123(6): 1339-43. [Abstract] [Full-text]
73. Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway.
    Int J Cancer, 123(6): 1311-7. [Abstract] [Full-text]
74. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Ann Surg, 248(2): 243-51. [Abstract] [Full-text]
75. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3.
    Oncogene, 27(32): 4467-77. [Abstract] [Full-text]
76. The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer.
    Abdom Imaging, 33(5): 604-10. [Abstract] [Full-text]
77. Expression of galectin-3 in the tumor immune response in colon cancer.
    Lab Invest, 88(8): 896-906. [Abstract] [Full-text]
78. Quality of colon cancer outcomes in hospitals with a high percentage of Medicaid patients.
    J Am Coll Surg, 207(2): 197-204. [Abstract] [Full-text]
79. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity.
    Hum Pathol, 39(8): 1229-33. [Abstract] [Full-text]
80. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984.
    Dis Colon Rectum, 51(8): 1185-91; discussion 1191-4. [Abstract] [Full-text]
81. The prognostic significance of RON and MET receptor coexpression in patients with colorectal cancer.
    Dis Colon Rectum, 51(8): 1268-74. [Abstract] [Full-text]
82. Associations between exercise, quality of life, and fatigue in colorectal cancer survivors.
    Dis Colon Rectum, 51(8): 1242-8. [Abstract] [Full-text]
83. Acute intestinal obstruction after endoscopic submucosal dissection: report of a case.
    Dis Colon Rectum, 51(8): 1295-7. [Abstract] [Full-text]
84. Most patients with colorectal tumors at young age do not visit a cancer genetics clinic.
    Dis Colon Rectum, 51(8): 1249-54. [Abstract] [Full-text]
85. Neoadjuvant therapy and anastomotic leak after tumor-specific mesorectal excision for rectal cancer.
    Dis Colon Rectum, 51(8): 1195-201. [Abstract] [Full-text]
86. Adenoma detection rate: the real indicator of quality in colonoscopy.
    Dis Colon Rectum, 51(8): 1217-20. [Abstract] [Full-text]
87. Multimedia article. Autonomic nerve-preserving total mesorectal excision in the laparoscopic era.
    Dis Colon Rectum, 51(8): 1279-82. [Abstract] [Full-text]
88. Design considerations in a sib-pair study of linkage for susceptibility loci in cancer.
    BMC Med Genet, 9: 64. [Abstract] [Full-text]
89. Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group.
    Ann Oncol, 19(8): 1442-9. [Abstract] [Full-text]
90. UFT (tegafur-uracil) in rectal cancer.
    Ann Oncol, 19(8): 1371-8. [Abstract] [Full-text]
91. Two distinct amplification events of the c-myc locus in a colorectal tumour.
    J Cell Physiol, 217(1): 34-9. [Abstract] [Full-text]
92. Pro-inflammatory prostaglandins and progression of colorectal cancer.
    Cancer Lett, 267(2): 197-203. [Abstract] [Full-text]
93. Randomized trial of $20 versus $50 incentives to increase physician survey response rates.
    Med Care, 46(8): 878-81. [Abstract] [Full-text]
94. Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer.
    Br J Cancer, 99(3): 459-63. [Abstract] [Full-text]
95. Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.
    Br J Cancer, 99(3): 502-12. [Abstract] [Full-text]
96. Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology.
    Br J Cancer, 99(3): 532-5. [Abstract] [Full-text]
97. Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
    Cancer Invest, 26(7): 708-17. [Abstract] [Full-text]
98. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma.
    Am J Surg Pathol, 32(8): 1182-9. [Abstract] [Full-text]
99. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.
    Biochem Biophys Res Commun, 374(1): 111-6. [Abstract] [Full-text]
100. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.
     Oncogene, 27(33): 4544-56. [Abstract] [Full-text]

© 2004-2010 Colorectal Cancer Research Today. All Rights Reserved.